COMPARATIVE EFFICACY OF HINGUVADI GHRITAM VERSUS SHUNTHI GHRITAM ALONG WITH VALUKA SVEDANA IN BOTH GROUPS IN THE MANAGEMENT OF AMAVATA (RHEUMATOID ARTHRITIS)

EVALUATION OF COMPARATIVE EFFICACY OF HINGHUWADHI GHRITAM VERSUS SHUNTHI GHRITAM ALONG WITH VALUKA SWEDANA IN IN MANAGEMENT OF AMAVATA (RHEUMATOID ARTHRITIS)

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/05/053046

Enrollment

120

Registered

2023-05-23

Start date

Unknown

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patient fulfilling the diagnostic criteria based on American Rheumatism Association (ARA) 1987. 2 Both Seropositive and Seronegative RA factor. 3 Subjects in the age group of 20-60 years of either sex. 4 Patients willing to give written consent.

Exclusion criteria

Exclusion criteria: 1 Subjects having chronicity for more than 10yrs and having severe crippling deformity. 2 Subjects suffering from Systemic diseases like uncontrolled Diabetes mellitus, Cardio-vascular, Hepatic or Renal disorders, Hypertension, AIDS, Left Ventricular Hypertrophy, Ischemic Heart Diseases, Tuberculosis, Other Rheumatic conditions like Osteoarthritis, Gout, Psoriatic arthritis. 3 Patients on methotrexate drugs. 4 Pregnant and lactating mothers.

Design outcomes

Primary

Measure	Time frame
ROM-by Goniometer Sandhishotha (joint swelling) Stiffness time Grip strength Foot pressure Walking time Timepoint: 4 weeks	—

Secondary

Measure	Time frame
Sandhi shoola(pain) Sparshasahatva (Tenderness) Aruchi Timepoint: 4 weeks	—

Countries

India

Contacts

Public ContactDrGKavitha

DATTA MEGHE INSTITUTE OF HIGHER EDUCATION RESEARCH

sadhanamisar@gmail.com9763732083

Outcome results